EMILY JOHNSON: Open Payments
NPI 1033997382 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 82 payments from 20 companies in 2025. Trend: 2023 $260 · 2024 $1,418 · 2025 $1,802
Food & beverage: $1,802
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $361 |
| AstraZeneca Pharmaceuticals LP | 6 | $245 |
| ABBVIE INC. | 15 | $209 |
| PFIZER INC. | 13 | $193 |
| E.R. Squibb & Sons, L.L.C. | 6 | $171 |
| Paratek Pharmaceuticals, Inc. | 1 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| Viatris Specialty LLC | 3 | $57 |
| Lilly USA, LLC | 3 | $56 |
Products named: CAPLYTA, AIRSUPRA, COBENFY, VRAYLAR, NURTEC ODT, REXULTI, ELIQUIS, NUZYRA.
Industry payments across NC — which companies pay providers there.
